M&A Deal Summary |
|
|---|---|
| Date | 2019-11-25 |
| Target | CannabidiolHemp |
| Sector | Digital Media |
| Buyer(s) | Cannabinoid Biosciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Life Science |
Cannabinoid Biosciences, Inc. is a biopharmaceutical company, which intends to engage in the discovery, development, and commercialization of cures and novel therapeutics from proprietary cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids product platform suitable for specific treatments in a broad range of disease areas. Cannabinoid Biosciences, Inc. was founded in 2014 and is based in Los Angeles, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Digital Media M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
